Mount Sinai rolls out predictive tool for COVID-19 mortality, focuses on 3 key clinical features

Researchers at New York City-based Mount Sinai Health System developed a COVID-19 mortality predictive model that can accurately and cost-effectively aid clinical staff in assessing COVID-19 patients’ risk of death, according to a study published in the October 2020 issue of The Lancet.

Advertisement

Using what the research team called “the largest clinical dataset to date,” they analyzed data from 5,051 Mount Sinai COVID-19 patients by deploying machine learning algorithms that focused on three clinical features: age, minimum oxygen saturation over the span of the medical encounter and type of encounter (inpatient, outpatient or telehealth). 

“Predicting mortality among patients with COVID-19 who present with a spectrum of complications is very difficult, hindering the prognostication and management of the disease,” Gaurav Pandey, PhD, a member of the research team, said in the study. “We aimed to develop an accurate prediction model of COVID-19 mortality using unbiased computational methods, and identify the clinical features most predictive of this outcome.”

The predictive model produced a vital sign that can be easily integrated into clinical staff’s workflows, allowing them to continually assess COVID-19 patients’ needs. The tool can flag patients with a high mortality risk so healthcare personnel can intervene more promptly to prevent death.

More articles on data analytics:
UCSF asks public to share their Google location data to improve contact tracing
12-health system consortium to answer public’s COVID-19 questions using patient data
Data unicorn debuts $3.4 billion IPO: 6 things to know about Snowflake

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.